By modulating inhibitory toll-like receptors (TLRs) and nuclear factor kappa B (NF-κB) signaling, CTRP3 reduces insulin resistance and obesity-related chronic inflammation [10]. Here, C1QTNF3 is linked to obesity due to melanocortin 4 receptor deficiency.